Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q1 2019 · 10-Q
Revenue$2.67K$2.67K−99.2% vs Q1 2018 Net Income-$703.62K-$703.62KN/M vs Q1 2018 EPS Diluted-$0.02-$0.02— vs Q1 2018 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Operating Cash Flow-$718,420N/M Free Cash Flowderived-$725,784N/M Margins · derivedGross margin-391.6%−442.3 pt vs Q1 2018
Operating margin-16828.5%−16833.1 pt vs Q1 2018
Net margin-26402.4%−26408.2 pt vs Q1 2018
ended Mar 31, 2019 · filed May 21, 2019 · 51 d after period end